Health systems and pharmaceutical companies will increasingly be relied upon to push back against the effects of surging temperatures and extreme weather events. Are they up to the task?
An unsettled debate: COVID vaccination remains polarizing in the U.S.
The results of a recent survey varied wildly by ethnicity, household income, mother’s education level and, perhaps least surprisingly, uptake of flu vaccines.
The past two years were all about COVID-19 vaccines and therapeutics. Now, imminent approvals in oncology, hematology and autoimmune disorders are set to enhance patient convenience.
These best-regarded companies show commitment to providing flexibility as well as a dedication to look after their employees’ well-being and professional growth.
How did I get here: Calliditas Therapeutics’ Andy Udell
Udell cuts a unique figure within the world of pharma leadership for a bunch of reasons. Here, he talks pandemic takeaways and a life lesson gleaned from Tommy Boy.